PerkinElmer and Cerep expand new kinase assay offerings
US-based healthcare company PerkinElmer and Cerep, a provider of drug candidate screening and profiling technologies, have expanded their kinase assay offering. Close to 200 new kinase assays validated
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.